Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression

BMC Anesthesiology

Research Article

Diederik Gommers¹  A. B. Johan Groeneveld¹  Esther N. van der Zee¹  Mohamud Egal² 

[1] Department of Intensive Care, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands;Department of Intensive Care, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands;Erasmus MC, P.O. Box 2040, Room H-602, 3000 CA, Rotterdam, The Netherlands;

关键词: Oliguria;    Mortality;    Perioperative care;    Critical care;   

DOI  :  10.1186/s12871-017-0316-4

 received in 2016-11-14, accepted in 2017-02-06,  发布年份 2017

来源: Springer

【 摘 要 】

BackgroundOliguria is associated with a decreased kidney- and organ perfusion, leading to organ damage and increased mortality. While the effects of correcting oliguria on renal outcome have been investigated frequently, whether urine output is a modifiable risk factor for mortality or simply an epiphenomenon remains unclear. We investigated whether targeting urine output, defined as achieving and maintaining urine output above a predefined threshold, in hemodynamic management protocols affects 30-day mortality in perioperative and critical care.MethodsWe performed a systematic review with a random-effects meta-analyses and meta-regression based on search strategy through MEDLINE, EMBASE and references in relevant articles. We included studies comparing conventional fluid management with goal-directed therapy and reporting whether urine output was used as target or not, and reporting 30-day mortality data in perioperative and critical care.ResultsWe found 36 studies in which goal-directed therapy reduced 30-day mortality (OR 0.825; 95% CI 0.684-0.995; P = 0.045). Targeting urine output within goal-directed therapy increased 30-day mortality (OR 2.66; 95% CI 1.06-6.67; P = 0.037), but not in conventional fluid management (OR 1.77; 95% CI 0.59-5.34; P = 0.305). After adjusting for operative setting, hemodynamic monitoring device, underlying etiology, use of vasoactive medication and year of publication, we found insufficient evidence to associate targeting urine output with a change in 30-day mortality (goal-directed therapy: OR 1.17; 95% CI 0.54-2.56; P = 0.685; conventional fluid management: OR 0.74; 95% CI 0.39-1.38; P = 0.334).ConclusionsThe principal finding of this meta-analysis is that after adjusting for confounders, there is insufficient evidence to associate targeting urine output with an effect on 30-day mortality. The paucity of direct data illustrates the need for further research on whether permissive oliguria should be a key component of fluid management protocols.

【 授权许可】

CC BY   
© The Author(s). 2017